Organogenesis Report issue

Contributed to NME For profit Phase 2 Phase 3 Phase 4
Founded: Canton MA United States (1985)
Status: No NME R&D (1985)

Organization Overview

First Clinical Trial
2007
NCT00587834
First Marketed Drug
2012
erwinia asparaginase (Erwinaze)
Last Known Activity
2023

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Organogenesis | Organogenesis Inc. | Organogenesis, Inc.